NIFTY
90.20  0.95%
 9580.30
S&P BSE SENSEX
223.51  0.69%
 32424.1
Sun Pharmaceutical Industries Ltd.
NSE : SUNPHARMA BSE : 524715 ISIN code : INE044A01036
on 29-May-2020
NSE
15.15    3.3%
Rs. 474.25
 
Days Low
Rs. 458.75
Days High
Rs. 481.45

Open Rs. 459.5
 
52 week Low
Rs. 315.2
52 week High
Rs.504.85
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.475.45
16.2    3.53%
on 29-May-2020
BSE
16.2    3.53%
Rs. 475.45
 
Days Low
Rs. 458
Days High
Rs. 481.6

Open Rs. 460
 
52 week Low
Rs. 312
52 week High
Rs.504.8
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.474.25
15.15    3.3%
 
 
Last Price (Rs.)  475.45 Value  198791729.00
Net Change (Rs.)  16.20 Best Buy  0.00
Volume  423029 Best Sell  0.00
Prev.Close (Rs.)  459.25 Best Quantity  0
Open (Rs.)  459.50 Sell Quantity  0
High (Rs.)  481.45 52-Week High (Rs.)  504.85
Low (Rs.)  458.75 52-Week Low (Rs.)  315.20
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  1140763.81
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital2399.30 2399.30 2399.30 
Share Capital2399.30 2399.30 2399.30 
Share Capital2399.30 2399.30 2399.30 
Share Capital2399.30 2399.30 2399.30 
Share Capital2399.30 2399.30 2399.30 
Currents Investments2479.50 447.60 400.10 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Dr. Reddys Lab 4073.80 676952 914.23 52.94 0.61
Divis Lab 2395.75 635996 280.36 47.72 0.67
Cipla 647.60 522121 215.85 27.63 0.46
Aurobindo Pharma 745.05 436554 213.23 28.54 0.34
Biocon 354.70 425640 62.81 43.19 0.28
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2020Dec 2019Sep 2019
Net Sales28360.8030135.5033732.90
Operating Profit14471.907211.7010932.40
PBDT13096.606224.109787.70
Net Profit11558.504687.608231.60
More> 
 
Company News
5/29/2020 12:00:00 AM
Cadila Healthcare, Sun Pharma and HCL Technologies to see some action ...
5/29/2020 12:00:00 AM
Sun Pharma, SPARC enter into worldwide license agreement for SCD044
5/29/2020 12:00:00 AM
Sun Pharma moves up after entering into worldwide license agreement fo...
More>
 
Ratios
   Earnings Per Share (Rs)3.40 
   Book NAV/Share(Rs)95.21 
   PAT Margin (%)6.58 
   Asset Turnover(x)0.33 
   PER(x)140.81 
   Yield(%)0.57 
   EV/Core EBITDA(x)39.99 
   M Cap / Sales11.16 
   Net Sales Growth(%)14.70 
   PAT Growth(%)167.18 
   Total Debt/Equity(x)0.28 
   Current Ratio(x)0.84 
   Quick Ratio(x)0.63 
   Total Debt/Mcap(x)0.06 
More>